Modeling effects of SGLT-2 inhibitor dapagliflozin treatment versus standard diabetes therapy on cardiovascular and microvascular outcomes-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Modeling effects of SGLT-2 inhibitor dapagliflozin treatment versus standard diabetes therapy on cardiovascular and microvascular outcomes

Published:2014-02-19 Issue:7 Volume:16 Page:628-635
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

Dziuba J.¹,Alperin P.¹,Racketa J.²,Iloeje U.³,Goswami D.¹,Hardy E.²,Perlstein I.⁴,Grossman H. L.¹,Cohen M.¹

Affiliation:

1. Department of Science, Archimedes, Inc.; San Francisco CA USA

2. Global Medicines Development, Astra-Zeneca; Wilmington DE USA

3. Research and Development, Bristol-Myers Squibb; New York NY USA

4. Department of Exploratory Clinical & Translational Research; Bristol-Myers Squibb; New York NY USA

Funder

AstraZeneca

Bristol-Myers Squibb

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/dom.12261/fullpdf

Reference35 articles.

1. http://www.who.int/mediacentre/factsheets/fs312/en/index.html

2. Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the Steno type 2 randomized study;Gaede;Lancet,1999

3. Risk of cardiovascular disease and all cause mortality among patients with type 2 diabetes prescribed oral antidiabetes drugs: retrospective cohort study using UK general practice research database;Tzoulaki;BMJ,2009

4. Management of hyperglycemia in type 2 diabetes: a patient-centered approach. A Position Statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD);Inzucchi;Diabetes Care,2012

5. Trends in the risk for coronary heart disease among adults with diagnosed diabetes in the US;Ford;Diabetes Care,2011

Cited by 91 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lower Risk of Incident Cataracts and Diabetic Retinopathy amongst Individuals Treated with Sodium Glucose Cotransporter-2 Inhibitor Compared to Dipeptidyl Peptidase-4 Inhibitor in Type 2 Diabetes Mellitus;2024-03-27

2. Sodium-Glucose Cotransporter 2 Inhibitors and Risk of Retinopathy in Patients With Type 2 Diabetes;JAMA Network Open;2023-12-20

3. Evaluation of the effect of sodium-glucose cotransporter-2 inhibitor treatment on choroidal vascular parameters in patients with type 2 diabetes mellitus;Photodiagnosis and Photodynamic Therapy;2023-12

4. Dapagliflozin ameliorated retinal vascular permeability in diabetic retinopathy rats by suppressing inflammatory factors;Journal of Diabetes and its Complications;2023-10

5. Effects of newer-generation anti-diabetics on diabetic retinopathy: a critical review;Graefe's Archive for Clinical and Experimental Ophthalmology;2023-09-20

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3